Biologically Active Small Molecules

An internal standard for the quantification of DHA by GC- or LC-MS.

An internal standard for the quantification of DHA by GC- or LC-MS.

An internal standard for the quantification of DHA by GC- or LC-MS.

The ethanolamine amide of DHA that has been detected in both brain and retina at concentrations similar to those for AEA binds to the rat brain CB1 receptor (Ki = 324 nM), which is approximately 10-fold higher than the Ki for AEA inhibits

The ethanolamine amide of DHA that has been detected in both brain and retina at concentrations similar to those for AEA binds to the rat brain CB1 receptor (Ki = 324 nM), which is approximately 10-fold higher than the Ki for AEA inhibits

The ethanolamine amide of DHA that has been detected in both brain and retina at concentrations similar to those for AEA binds to the rat brain CB1 receptor (Ki = 324 nM), which is approximately 10-fold higher than the Ki for AEA inhibits

The ethanolamine amide of DHA that has been detected in both brain and retina at concentrations similar to those for AEA binds to the rat brain CB1 receptor (Ki = 324 nM), which is approximately 10-fold higher than the Ki for AEA inhibits

An internal standard for the quantification of DHEA by GC- or LC-MS.

An internal standard for the quantification of DHEA by GC- or LC-MS.

An internal standard for the quantification of DHEA by GC- or LC-MS.

Consists of docosahexaenoic acid, an &omega-3 PUFA, with glycine attached at its carboxy terminus.

Consists of docosahexaenoic acid, an &omega-3 PUFA, with glycine attached at its carboxy terminus.